389 related articles for article (PubMed ID: 22260662)
41. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
[TBL] [Abstract][Full Text] [Related]
42. Autotaxin inhibitors: a patent review.
Barbayianni E; Magrioti V; Moutevelis-Minakakis P; Kokotos G
Expert Opin Ther Pat; 2013 Sep; 23(9):1123-32. PubMed ID: 23641951
[TBL] [Abstract][Full Text] [Related]
43. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
D'Souza K; Paramel GV; Kienesberger PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
[TBL] [Abstract][Full Text] [Related]
44. ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation.
Nishioka T; Arima N; Kano K; Hama K; Itai E; Yukiura H; Kise R; Inoue A; Kim SH; Solnica-Krezel L; Moolenaar WH; Chun J; Aoki J
Sci Rep; 2016 Mar; 6():23433. PubMed ID: 27005960
[TBL] [Abstract][Full Text] [Related]
45. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
46. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.
Brindley DN; Lin FT; Tigyi GJ
Biochim Biophys Acta; 2013 Jan; 1831(1):74-85. PubMed ID: 22954454
[TBL] [Abstract][Full Text] [Related]
47. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
48. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.
Zhang R; Wang J; Ma S; Huang Z; Zhang G
BMC Cell Biol; 2011 Mar; 12():11. PubMed ID: 21406114
[TBL] [Abstract][Full Text] [Related]
49. Autotaxin: structure-function and signaling.
Perrakis A; Moolenaar WH
J Lipid Res; 2014 Jun; 55(6):1010-8. PubMed ID: 24548887
[TBL] [Abstract][Full Text] [Related]
50. Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis.
Zhao Y; Hasse S; Vaillancourt M; Zhao C; Davis L; Boilard E; Fortin P; Di Battista J; Poubelle PE; Bourgoin SG
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884486
[TBL] [Abstract][Full Text] [Related]
51. ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways.
Li S; Xiong C; Zhang J
FEBS Lett; 2012 Mar; 586(6):792-7. PubMed ID: 22314276
[TBL] [Abstract][Full Text] [Related]
52. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
[TBL] [Abstract][Full Text] [Related]
53. 2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition.
Fukasawa K; Gotoh M; Uwamizu A; Hirokawa T; Ishikawa M; Shimizu Y; Yamamoto S; Iwasa K; Yoshikawa K; Aoki J; Murakami-Murofushi K
Sci Rep; 2021 Aug; 11(1):17360. PubMed ID: 34462512
[TBL] [Abstract][Full Text] [Related]
54. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
[TBL] [Abstract][Full Text] [Related]
55. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
Gupte R; Patil R; Liu J; Wang Y; Lee SC; Fujiwara Y; Fells J; Bolen AL; Emmons-Thompson K; Yates CR; Siddam A; Panupinthu N; Pham TC; Baker DL; Parrill AL; Mills GB; Tigyi G; Miller DD
ChemMedChem; 2011 May; 6(5):922-35. PubMed ID: 21465666
[TBL] [Abstract][Full Text] [Related]
56. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
Ray U; Roy SS
FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
[TBL] [Abstract][Full Text] [Related]
57. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease.
Ramesh S; Govindarajulu M; Suppiramaniam V; Moore T; Dhanasekaran M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933579
[TBL] [Abstract][Full Text] [Related]
58. Autotaxin-lysophosphatidic acid-LPA
Aikawa S; Kano K; Inoue A; Wang J; Saigusa D; Nagamatsu T; Hirota Y; Fujii T; Tsuchiya S; Taketomi Y; Sugimoto Y; Murakami M; Arita M; Kurano M; Ikeda H; Yatomi Y; Chun J; Aoki J
EMBO J; 2017 Jul; 36(14):2146-2160. PubMed ID: 28588064
[TBL] [Abstract][Full Text] [Related]
59. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
[TBL] [Abstract][Full Text] [Related]
60. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y
Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
